MwanzoBHM0 • FRA
add
BACHEM HOLDING AG
Bei iliyotangulia
€ 78.35
Bei za siku
€ 74.55 - € 74.55
Bei za mwaka
€ 51.25 - € 81.50
Thamani ya kampuni katika soko
5.26B CHF
Wastani wa hisa zilizouzwa
28.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
SWX
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 191.04M | 4.70% |
Matumizi ya uendeshaji wa biashara | 4.65M | -61.22% |
Mapato halisi | 49.35M | 17.36% |
Kiwango cha faida halisi | 25.83 | 12.11% |
Mapato kwa kila hisa | — | — |
EBITDA | 63.83M | 9.45% |
Asilimia ya kodi ya mapato | 1.53% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 30.99M | -67.45% |
Jumla ya mali | 2.11B | 9.66% |
Jumla ya dhima | 650.41M | 22.28% |
Jumla ya hisa | 1.46B | — |
hisa zilizosalia | 74.94M | — |
Uwiano wa bei na thamani | 4.03 | — |
Faida inayotokana na mali | 5.95% | — |
Faida inayotokana mtaji | 8.26% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 49.35M | 17.36% |
Pesa kutokana na shughuli | 92.80M | 220.31% |
Pesa kutokana na uwekezaji | -89.05M | -624.68% |
Pesa kutokana na ufadhili | -2.81M | -391.01% |
Mabadiliko halisi ya pesa taslimu | elfu 923.00 | -94.31% |
Mtiririko huru wa pesa | -43.10M | -92.30% |
Kuhusu
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacture of peptides and complex organic molecules for use as active pharmaceutical ingredients. The company focuses on peptide-based therapeutics, including large-scale commercial production and process development for pharmaceutical applications. It was founded in 1971 and is a subsidiary of Ingro Finanz AG.
The head office is in Bubendorf in the canton of Basel-Landschaft. Bachem operates production facilities in Vionnaz, Vista and Torrance, and St Helens, as well as a sales and distribution site in Tokyo.
Bachem is one of the largest manufacturers of peptide-based APIs globally, supplying pharmaceutical and biotechnology companies with products used in both clinical development and commercial therapies.
In recent years, the company has expanded its manufacturing capacity, including new large-scale production facilities in Switzerland and the United States.
At the end of 2025, the company employed 2,511 people, reported revenue of CHF 695.1 million, and net income of CHF 148.8 million. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1971
Tovuti
Wafanyakazi
2,363
